Clinical Trial Update: Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Umbilical Cord Lining Stem Cells (ULSC) for COVID-19 related ARDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Umbilical Cord Lining Stem Cells (ULSC)

Snippet

Sponsor: Restem, LLC. | Conditions: Covid19, Corona Virus Infection | Phase 1, Phase 2 | Status: COMPLETED